Treatment of microalbuminuria in metabolic syndrome (survey)

Panova, Gordana and Panova, Blagica and Velickova, Nevenka and Nikolovska, Lence and Dzidrova, Violeta (2012) Treatment of microalbuminuria in metabolic syndrome (survey). In: 35 International Medical Scientific Congress for medical students and young doctors, 08 May 2012, Ohrid, Macedonia.

[thumbnail of 1.pdf]

Download (101kB) | Preview


Unlike descriptions of E.Kylin [1] obezitas, hypertension, hyperglycemia and hyperuricemia, supplemented by G.Reaven [2] as an association between insulin resistance (hiperinsulinizam, impaired glucose tolerance), dyslipoproteinemia and hypertension defined as “X syndrome”, C.Bouchard and L.Perusse [3] in metabolic syndrome (MS) means “cluster of atherogenic disease, diabetes and hypertension secondary hiperinsulinizam (the result of insulin resistance). Microalbuminuria, as a component of MS, according to the WHO definition is very rare in people with normal glucose tolerance. It is the least abundant element of MS in patients with type 2 diabetes mellitus.

Item Type: Conference or Workshop Item (Paper)
Uncontrolled Keywords: Metabolic syndrome (MS), microalbuminuria, neuroprotection.
Subjects: Medical and Health Sciences > Basic medicine
Medical and Health Sciences > Clinical medicine
Divisions: Faculty of Medical Science
Depositing User: Gordana Panova
Date Deposited: 27 Aug 2013 11:30
Last Modified: 27 Aug 2013 13:42

Actions (login required)

View Item View Item